| |
| |
|
| Insider
Information: |
Negro-Vilar Andres |
| Relationship: |
Exe V-P, R & D, CSO |
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
7,233 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$516,581 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
7,233 |
|
|
| Total
Value |
$516,581 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Ligand Pharmaceuticals Inc |
LGND |
Exe V-P, R & D, CSO |
2006-12-14 |
7,233 |
2003-06-30 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
7 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| LGND |
Ligand Pharmaceuticals In... |
Exe V-P, R & D, CSO |
• – – |
2006-12-14 |
4 |
OE |
$7.63 |
$50,828 |
D/D |
6,666 |
8,274 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Exe V-P, R & D, CSO |
• – – |
2006-12-14 |
4 |
S |
$11.19 |
$74,586 |
D/D |
(6,666) |
7,233 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Exe V-P, R & D, CSO |
• – – |
2006-12-13 |
4 |
OE |
$7.63 |
$38,125 |
D/D |
5,000 |
12,233 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Exe V-P, R & D, CSO |
• – – |
2006-12-13 |
4 |
S |
$10.87 |
$54,373 |
D/D |
(5,000) |
7,233 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Exe V-P, R & D, CSO |
• – – |
2006-12-11 |
4 |
OE |
$7.25 |
$224,375 |
D/D |
30,000 |
12,810 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Exe V-P, R & D, CSO |
• – – |
2006-12-11 |
4 |
S |
$10.76 |
$322,650 |
D/D |
(30,000) |
7,233 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Exe V-P, R & D, CSO |
• – – |
2003-06-30 |
4 |
A |
$4.65 |
$6,184 |
D/D |
1,330 |
7,233 |
|
- |
|
7 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
